Quinn William P.'s Form 4 filing
Bolt Biotherapeutics, Inc. (BOLT) · filed Dec 9, 2021
- Accession no.
- 0000899243-21-047518
- Filed
- Dec 9, 2021
- Trade date
- Jun 4-Dec 8, 2021
- Filing delay
- 188 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $44.1K. It was filed 188 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Quinn William P.CIK 0001724190 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2021 | Common Stock | PPurchaseAcquired | +1,221 | $16.65 | +$20,329.65 | 15,119 | Direct | |
| Dec 6, 2021 | Common Stock | PPurchaseAcquired | +35 | $4.64 | +$162.4 | 15,154 | Direct | |
| Dec 8, 2021 | Common Stock | PPurchaseAcquired | +5,000 | $4.72 | +$23,600 | 20,154 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.